D-Index & Metrics Best Publications
S. Vincent Rajkumar

S. Vincent Rajkumar

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 138 Citations 77,345 747 World Ranking 724 National Ranking 439

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Multiple myeloma

His primary areas of investigation include Multiple myeloma, Internal medicine, Surgery, Gastroenterology and Monoclonal gammopathy of undetermined significance. The Multiple myeloma study combines topics in areas such as Clinical trial, Disease, Bone marrow and Pathology. His Internal medicine study frequently draws connections between adjacent fields such as Oncology.

The Oncology study which covers Plasmacytoma that intersects with Macroglobulinemia. His Gastroenterology research is multidisciplinary, incorporating perspectives in Chemotherapy, Hazard ratio, Myeloma protein, Survival analysis and Risk factor. His Monoclonal gammopathy of undetermined significance research is multidisciplinary, relying on both Malignancy, Immunofixation, Proteinuria and Confidence interval.

His most cited work include:

  • A phase 2 study of bortezomib in relapsed, refractory myeloma. (2325 citations)
  • Improved survival in multiple myeloma and the impact of novel therapies (1718 citations)
  • International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. (1706 citations)

What are the main themes of his work throughout his whole career to date?

S. Vincent Rajkumar spends much of his time researching Internal medicine, Multiple myeloma, Oncology, Gastroenterology and Surgery. His study in Lenalidomide, Dexamethasone, Bortezomib, Transplantation and Amyloidosis falls under the purview of Internal medicine. Immunofixation is closely connected to Monoclonal gammopathy of undetermined significance in his research, which is encompassed under the umbrella topic of Multiple myeloma.

When carried out as part of a general Oncology research project, his work on Progression-free survival is frequently linked to work in In patient, therefore connecting diverse disciplines of study. His Gastroenterology study combines topics in areas such as Hazard ratio, Survival rate, Primary systemic amyloidosis, Myeloma protein and Survival analysis. Surgery connects with themes related to Cohort in his study.

He most often published in these fields:

  • Internal medicine (64.11%)
  • Multiple myeloma (62.08%)
  • Oncology (25.32%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (64.11%)
  • Multiple myeloma (62.08%)
  • Oncology (25.32%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Internal medicine, Multiple myeloma, Oncology, Gastroenterology and AL amyloidosis. His Amyloidosis, Dexamethasone, Ixazomib and Bortezomib study in the realm of Internal medicine interacts with subjects such as In patient. He works in the field of Multiple myeloma, namely Lenalidomide.

S. Vincent Rajkumar has included themes like Hematopoietic stem cell transplantation, Stem cell and Daratumumab in his Oncology study. The various areas that he examines in his Gastroenterology study include Monoclonal gammopathy of undetermined significance, Waldenstrom macroglobulinemia, Bone marrow and Hazard ratio. His AL amyloidosis research incorporates elements of Retrospective cohort study, Family medicine and Urology.

Between 2017 and 2021, his most popular works were:

  • Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance. (156 citations)
  • Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study (136 citations)
  • International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders (91 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

S. Vincent Rajkumar mainly investigates Internal medicine, Multiple myeloma, Oncology, Amyloidosis and Lenalidomide. His study ties his expertise on Gastroenterology together with the subject of Internal medicine. His research in Multiple myeloma intersects with topics in Clinical trial and Transplantation.

His biological study deals with issues like Hematopoietic stem cell transplantation, which deal with fields such as Survival analysis. His Amyloidosis study also includes

  • AL amyloidosis which intersects with area such as Bone marrow, Survival rate and Urology,
  • Immunoglobulin light chain which is related to area like Immunofixation. As a part of the same scientific study, he usually deals with the Lenalidomide, concentrating on Randomized controlled trial and frequently concerns with MEDLINE.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A phase 2 study of bortezomib in relapsed, refractory myeloma.

Paul G. Richardson;Bart Barlogie;James Berenson;Seema Singhal.
The New England Journal of Medicine (2003)

3226 Citations

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

S. Vincent Rajkumar;Meletios A. Dimopoulos;Antonio Palumbo;Joan Blade.
Lancet Oncology (2014)

2775 Citations

Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

Robert A. Kyle;Morie A. Gertz;Thomas E. Witzig;John A. Lust.
Mayo Clinic Proceedings (2003)

2466 Citations

Improved survival in multiple myeloma and the impact of novel therapies

Shaji K. Kumar;S. Vincent Rajkumar;Angela Dispenzieri;Martha Q. Lacy.
Blood (2008)

2418 Citations

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

Robert A. Kyle;Terry M. Therneau;S. Vincent Rajkumar;Janice R. Offord.
The New England Journal of Medicine (2002)

1597 Citations

Drug therapy: Multiple myeloma

Robert A. Kyle;S. Vincent Rajkumar.
The New England Journal of Medicine (2004)

1499 Citations

Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America

Donna M. Weber;Christine Chen;Ruben Niesvizky;Michael Wang.
The New England Journal of Medicine (2007)

1481 Citations

Initial genome sequencing and analysis of multiple myeloma

Michael A. Chapman;Michael S. Lawrence;Jonathan J. Keats;Kristian Cibulskis.
Nature (2011)

1338 Citations

Prevalence of Monoclonal Gammopathy of Undetermined Significance

Robert A. Kyle;Terry M. Therneau;S. Vincent Rajkumar;Dirk R. Larson.
The New England Journal of Medicine (2006)

1298 Citations

Phase III Clinical Trial of Thalidomide Plus Dexamethasone Compared With Dexamethasone Alone in Newly Diagnosed Multiple Myeloma: A Clinical Trial Coordinated by the Eastern Cooperative Oncology Group

S. Vincent Rajkumar;Emily Blood;David Vesole;Rafael Fonseca.
Journal of Clinical Oncology (2006)

1209 Citations

Editorial Boards

Blood Cancer Journal
(Impact Factor: 9.812)

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing S. Vincent Rajkumar

Kenneth C. Anderson

Kenneth C. Anderson

Harvard University

Publications: 453

Paul G. Richardson

Paul G. Richardson

Harvard University

Publications: 400

Meletios A. Dimopoulos

Meletios A. Dimopoulos

National and Kapodistrian University of Athens

Publications: 393

Angela Dispenzieri

Angela Dispenzieri

Mayo Clinic

Publications: 341

Shaji Kumar

Shaji Kumar

Mayo Clinic

Publications: 329

Morie A. Gertz

Morie A. Gertz

Mayo Clinic

Publications: 324

Nikhil C. Munshi

Nikhil C. Munshi

Harvard University

Publications: 281

Philippe Moreau

Philippe Moreau

University of Nantes

Publications: 257

Evangelos Terpos

Evangelos Terpos

National and Kapodistrian University of Athens

Publications: 235

Gareth J. Morgan

Gareth J. Morgan

New York University

Publications: 235

Antonio Palumbo

Antonio Palumbo

University of Turin

Publications: 233

Hartmut Goldschmidt

Hartmut Goldschmidt

University Hospital Heidelberg

Publications: 230

Ola Landgren

Ola Landgren

University of Miami

Publications: 229

Pieter Sonneveld

Pieter Sonneveld

Erasmus University Rotterdam

Publications: 215

Sagar Lonial

Sagar Lonial

Emory University

Publications: 196

Robert A. Kyle

Robert A. Kyle

Mayo Clinic

Publications: 195

Trending Scientists

Joan Costa-Font

Joan Costa-Font

London School of Economics and Political Science

Lothar Reichel

Lothar Reichel

Kent State University

Adrián Mota-Babiloni

Adrián Mota-Babiloni

Jaume I University

Stefano Pampanin

Stefano Pampanin

Sapienza University of Rome

Helmut Ritter

Helmut Ritter

Heinrich Heine University Düsseldorf

Hiroyuki Nakazawa

Hiroyuki Nakazawa

Hoshi University

Vojislav R. Stamenkovic

Vojislav R. Stamenkovic

University of California, Irvine

Martina H. Stenzel

Martina H. Stenzel

UNSW Sydney

Junping Zhang

Junping Zhang

Harbin Institute of Technology

Eric D. Wieben

Eric D. Wieben

Mayo Clinic

Raf Aerts

Raf Aerts

KU Leuven

Sabita Roy

Sabita Roy

University of Miami

Ashok K. Chopra

Ashok K. Chopra

The University of Texas Medical Branch at Galveston

David Cottrell

David Cottrell

University of Leeds

Cynthia D. Fisher

Cynthia D. Fisher

Bond University

Damien Ségransan

Damien Ségransan

University of Geneva

Something went wrong. Please try again later.